Teladoc Health (NYSE:TDOC) Sets New 1-Year Low at $13.54

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) hit a new 52-week low on Monday . The stock traded as low as $13.54 and last traded at $13.57, with a volume of 3128879 shares. The stock had previously closed at $14.21.

Wall Street Analysts Forecast Growth

TDOC has been the topic of several recent analyst reports. SVB Leerink initiated coverage on Teladoc Health in a report on Monday, February 26th. They issued a "market perform" rating and a $17.00 price target on the stock. Canaccord Genuity Group reduced their price target on Teladoc Health from $34.00 to $28.00 and set a "buy" rating on the stock in a report on Wednesday, February 21st. Cantor Fitzgerald initiated coverage on Teladoc Health in a report on Thursday, February 29th. They issued an "overweight" rating and a $22.00 price target on the stock. Royal Bank of Canada reduced their price target on Teladoc Health from $30.00 to $25.00 and set an "outperform" rating on the stock in a report on Wednesday, February 21st. Finally, Truist Financial reduced their price target on Teladoc Health from $23.00 to $17.00 and set a "hold" rating on the stock in a report on Wednesday, March 6th. Eight investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $22.23.

Teladoc Health Price Performance

The company has a current ratio of 3.54, a quick ratio of 3.47 and a debt-to-equity ratio of 0.66. The firm has a market cap of $2.29 billion, a P/E ratio of -10.10 and a beta of 0.94. The firm has a 50-day simple moving average of $16.16 and a 200-day simple moving average of $18.06.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.05. The business had revenue of $660.50 million for the quarter, compared to analysts' expectations of $670.79 million. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The business's revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter last year, the firm earned ($0.23) EPS. As a group, analysts forecast that Teladoc Health, Inc. will post -1.07 EPS for the current year.

Insider Activity

In other news, CTO Nikolaos P. Nanis sold 2,866 shares of the stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $41,614.32. Following the completion of the sale, the chief technology officer now owns 69,850 shares in the company, valued at approximately $1,014,222. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, COO Michael Willem Waters sold 4,523 shares of the stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total transaction of $86,751.14. Following the completion of the sale, the chief operating officer now owns 38,570 shares in the company, valued at approximately $739,772.60. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CTO Nikolaos P. Nanis sold 2,866 shares of the stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $41,614.32. Following the sale, the chief technology officer now owns 69,850 shares of the company's stock, valued at approximately $1,014,222. The disclosure for this sale can be found here. In the last quarter, insiders sold 134,441 shares of company stock worth $2,025,041. Insiders own 1.63% of the company's stock.

Hedge Funds Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its stake in shares of Teladoc Health by 116.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,593,819 shares of the health services provider's stock valued at $93,070,000 after buying an additional 1,935,496 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Teladoc Health by 11.8% during the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider's stock valued at $377,451,000 after buying an additional 1,855,480 shares during the last quarter. Norges Bank purchased a new position in shares of Teladoc Health during the 4th quarter valued at about $34,632,000. Point72 Asset Management L.P. purchased a new position in shares of Teladoc Health during the 4th quarter valued at about $31,398,000. Finally, Two Sigma Investments LP raised its stake in shares of Teladoc Health by 68.6% during the 1st quarter. Two Sigma Investments LP now owns 3,191,291 shares of the health services provider's stock valued at $82,654,000 after buying an additional 1,298,934 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.